Ryosuke Fukushima

Dr. Ryosuke Fukushima

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
MTMariko Tsukagoshi
Mariko Tsukagoshi
KAKenichiro Araki
Kenichiro Araki
TITakamichi Igarashi
Takamichi Igarashi
NINorihiro Ishii
Norihiro Ishii
SKShunsuke Kawai
Shunsuke Kawai
KSKen Shirabe
Ken Shirabe
Increasing evidence suggests that nutritional indices, including the geriatric nutritional risk index (GNRI) and prognostic nutritional index (PNI), are predictors of poor prognosis in patients with hepatocellular carcinoma (HCC). Hence, this study aimed to explore the value of the GNRI and PNI in evaluating postoperative prognosis in patients with HCC, particularly regarding its recurrence patterns. We performed a retrospective analysis of 203 patients with HCC who underwent initial hepatic resection. Patients were divided into two groups according to the GNRI (cutoff: 98) and PNI (cutoff: 45). The GNRI and PNI were significantly associated with body composition (body mass index and skeletal muscle mass index), hepatic function (Child-Pugh Score), tumor factors (tumor size and microvascular invasion), and perioperative factors (blood loss and postoperative hospitalization). Patients with a low PNI or low GNRI had significantly worse overall survival (OS) and recurrence-free survival. Patients with early recurrence had lower PNI and GNRI scores than those without early recurrence. Patients with extrahepatic recurrence had lower PNI and GNRI scores than those without extrahepatic recurrence. The PNI and GNRI might be useful in predicting the prognosis and recurrence patterns of patients with HCC after hepatic resection.

14 June 2022 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
RFRyosuke Fukushima
Ryosuke Fukushima
NINorihiro Ishii
Norihiro Ishii
NHNorifumi Harimoto
Norifumi Harimoto
KAKenichiro Araki
Kenichiro Araki
AWAkira Watanabe
Akira Watanabe
KSKen Shirabe
Ken Shirabe
Background: Although visceral aneurysms are relatively rare, it can be life-threatening in case it ruptures. We report a case of Mirizzi syndrome accompanied by a pseudoaneurysm that ruptured into the gallbladder. Case presentation: The patient was a 73-year-old woman with persistent gastrointestinal bleeding and progressive jaundice. Examination revealed a pseudoaneurysm in the gallbladder artery or hepatic artery branch, and biliary hemorrhage due to gallbladder perforation was suspected. Urgent abdominal angiography revealed a pseudoaneurysm measuring 50 × 32 mm that had ruptured directly from the right hepatic artery or the cystic artery into the gallbladder. The pseudoaneurysm was successfully coiled and the bleeding was stopped. The presence of ongoing obstruction due to Mirizzi syndrome resulted in an emergency cholecystectomy being performed on the same day. On removing the impacted gallstone from the neck of the gallbladder, we found an obstruction between the lateral wall of the common bile duct and the gallbladder, this condition was diagnosed as Mirizzi syndrome with a biliobiliary fistula. After removing the impacted gallstone, a T-tube was inserted into the common bile duct. Bile leakage was observed postoperatively, but it improved with drainage. The patient fully recovered. Conclusions: We present our experience with a case of Mirizzi syndrome accompanied by a ruptured pseudoaneurysm successfully treated with coil embolization followed by cholecystectomy. In this case, the pseudoaneurysm may have been caused by inflammation due to cholecystitis or compression of the arterial wall by a gallstone. To the best of our knowledge, Mirizzi syndrome associated with pseudoaneurysm rupture is rare. Our study suggested that cholecystectomy preceded by transcatheter arterial embolization is an effective strategy to control bleeding in patients with hemobilia due to aneurysm.

11 March 2024 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
RFRyosuke Fukushima
Ryosuke Fukushima
NHNorifumi Harimoto
Norifumi Harimoto
SKShunsuke Kawai
Shunsuke Kawai
NINorihiro Ishii
Norihiro Ishii
MTMariko Tsukagoshi
Mariko Tsukagoshi
KSKen Shirabe
Ken Shirabe

8 July 2025 in Hepatology Research
Verified
Journal Article
Closed access
NINorihiro Ishii
Norihiro Ishii
KAKenichiro Araki
Kenichiro Araki
DGDolgormaa Gantumur
Dolgormaa Gantumur
RFRyosuke Fukushima
Ryosuke Fukushima
TOTakayuki Okuyama
Takayuki Okuyama
KSKen Shirabe
Ken Shirabe

12 July 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
MTMariko Tsukagoshi
Mariko Tsukagoshi
KAKenichiro Araki
Kenichiro Araki
NKNorio Kubo
Norio Kubo
TITakamichi Igarashi
Takamichi Igarashi
SKShunsuke Kawai
Shunsuke Kawai
KSKen Shirabe
Ken Shirabe
Background/Objectives: This study aimed to investigate the impact of preoperative weight loss on long-term postoperative survival and the significance of preoperative nutrition on perioperative weight change in patients with pancreatic cancer. Methods: Overall, 125 patients who underwent radical resection for invasive pancreatic ductal carcinoma were retrospectively analyzed. The preoperative weight loss rate (pre-%WL) from the initial visit to immediately before surgery was calculated. Patients were classified by pre-%WL into the weight-loss (≥6% loss) and weight-maintenance (<6% loss) groups. The association of pre-%WL with postoperative outcomes and long-term survival was assessed. We evaluated preoperative nutrition’s effect on perioperative weight change. Results: The study cohort included 91 (73%) and 34 (27%) patients with weight maintenance and weight loss, respectively. Specifically, the weight-loss group had a longer operative time (p = 0.025) and greater blood loss (p = 0.018) than the weight-maintenance group. Patients with weight loss had significantly poorer recurrence-free survival (RFS; 8.7 vs. 17.8 months, p = 0.004) and overall survival (OS; 18.1 vs. 45.2 months, p = 0.002) than those with weight maintenance. Multivariate analysis revealed weight loss as an independent prognostic indicator of poor RFS (hazard ratio = 2.07; p = 0.003) and OS (hazard ratio = 2.55; p = 0.0008). The presence or absence of preoperative nutritional therapy was not correlated with the pre-%WL but was associated with postoperative (by the time of discharge) weight loss rate (median weight change rate: −2.9% vs. −5.6%, p = 0.001). Conclusions: Preoperative weight loss ≥ 6% was associated with poor RFS and OS in patients with pancreatic cancer. Although preoperative nutritional therapy did not suppress preoperative weight loss, it suppressed postoperative weight loss.

18 January 2024 in Research Square
Verified
Preprint
Open access
PDF file
RFRyosuke Fukushima
Ryosuke Fukushima
NHNorifumi Harimoto
Norifumi Harimoto
TOTakayuki Okuyama
Takayuki Okuyama
TSTakaomi Seki
Takaomi Seki
KHKouki Hoshino
Kouki Hoshino
KSKen Shirabe
Ken Shirabe
Background Sarcopenia is a poor prognostic factor in cancer patients. In recent years, there have been reports that serum creatinine and cystatin C (Cr/CysC) ratio is associated with sarcopenia. However, the prognostic value of the Cr/CysC ratio in biliary tract cancer is unclear. We evaluated the impact of the Cr/CysC ratio on sarcopenia and prognosis in biliary tract cancer. Methods We retrospectively reviewed the records of 190 patients with biliary tract cancer who had undergone surgical resection from January 2017 to March 2023. Frozen serum samples collected at the time of surgery were used to measure CysC. We calculated the Cr/CysC ratio and investigated the relationship with sarcopenia and the prognostic significance. Results Serum Cr/CysC ratio was statistically related to both skeletal muscle index and handgrip strength, both of which are diagnostic criteria for sarcopenia (skeletal muscle index: R2 = 0.096, p < 0.001, handgrip strength: R2 = 0.20, p < 0.001). The optimal cutoff value of the Cr/CysC ratio for sarcopenia was 0.848. The low Cr/CysC ratio group was significantly associated with higher preoperative CRP and lower albumin, lower skeletal muscle index, lower handgrip strength, and higher intramuscular adipose tissue content. In multivariate analysis, patients with a low Cr/CysC ratio showed poorer overall survival (hazard ratio 2.60, 95% confidence interval 1.07–6.29, p = 0.033), which was significantly worse than in those with a high Cr/CysC ratio. Conclusions The Cr/CysC ratio could be used as a marker to evaluate sarcopenia in patients with biliary tract cancer. Moreover, a low Cr/CysC ratio predicts poor prognosis in biliary tract cancer patients.